Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-15 · accession 0001415889-24-004187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-16 | 2024-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | F - Tax | $35.91 | -5,040 | 164.0K | -3% | -$181.0K |
| D | 2024-02-16 | 2024-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | +3,386 | 160.5K | +2% | $0 |
| D | 2024-02-16 | 2024-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | A - Grant | $0.00 | +8,479 | 167.8K | +5% | $0 |
| D | 2024-02-16 | 2024-02-15 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | -3,386 | 3,386 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | F | D | 1,208 | $35.91 | 159,321 | D | — | — | (F1) The reported disposition of 1,208 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. |
| 2 | Common | Common Stock | 2024-02-15 | F | D | 3,832 | $35.91 | 163,968 | D | — | — | (F3) The reported disposition of 3,832 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. |
| 3 | Common | Common Stock | 2024-02-15 | M | A | 3,386 | $0.00 | 160,529 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-15 | A | A | 8,479 | $0.00 | 167,800 | D | — | — | (F2) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |
| 5 | Derivative | Restricted Stock Units | 2024-02-15 | M | D | 3,386 | $0.00 | 3,386 | D | $0.00 · — to — | 3,386 Common Stock | (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |